Ha, K., Fiskus, W., Choi, D. S., Bhaskara, S., Cerchietti, L., Devaraj, S. G. T., . . . Bhalla, K. N. (2014). Histone deacetylase inhibitor treatment induces ‘BRCAness’ and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells. Impact Journals LLC.
シカゴスタイル引用形Ha, Kyungsoo, et al. Histone Deacetylase Inhibitor Treatment Induces ‘BRCAness’ and Synergistic Lethality With PARP Inhibitor and Cisplatin against Human Triple Negative Breast Cancer Cells. Impact Journals LLC, 2014.
MLA引用形式Ha, Kyungsoo, et al. Histone Deacetylase Inhibitor Treatment Induces ‘BRCAness’ and Synergistic Lethality With PARP Inhibitor and Cisplatin against Human Triple Negative Breast Cancer Cells. Impact Journals LLC, 2014.